The fact
This authorization covers a miniaturized device for self-administering emergency treatments.
Crossject could market this product in the United States as early as 2027, expanding its market.
Click the link to read an article on the topic:
This authorization covers a miniaturized device for self-administering emergency treatments.
Crossject could market this product in the United States as early as 2027, expanding its market.